Table 2.
Change | Precontrast Phase | Arterial Phase | Portal Venous Phase | Late Dynamic Phase |
---|---|---|---|---|
Change in response A | NA | BMI (P < .001); injection volume (P < .001) | BMI (P < .05); injection volume (P < .001) | BMI (P < .05); imaging site (P < .05) |
Change in response B | NA | None | None | None |
Change in minimum HR | None | None | None | None |
Change in maximum HR | Imaging site (P < .05) | Age (P < .001); injection volume (P < .05) | None | None |
Change in minimum Spo2 | None | None | None | None |
Change in maximum Spo2 | None | Age (P < .01); BMI (P < .05) | Age (P < .005); BMI (P < .05) | Age (P < .001) |
Note.—Predictors are given as predictor (P value). P < .05 was considered to indicate a statistically significant difference. NA = not applicable. Spo2 was measured with continuous pulse oxymetry. Question A: “How difficult was it to hold your breath?” Question B: “Do you feel short of breath now?”